Condition: Gastric Adenocarcinoma · Gastroesophageal Junction (GEJ) Adenocarcinoma · Sponsor: National Cancer Center, Japan
To evaluate the clinical efficacy of perioperative treatment with S-1 + oxaliplatin (SOX)+ HLX10 compared with SOX as the control in patients with cT3-4N1-3M0 PD-L1-positive (CPS ≥ 5) locally advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma, in a placebo-controlled, double-blind, randomized phase II investigator-initiated clinical study.
This description comes directly from the study's public registry record.
Ken Kato, M.D., Ph.D. · +81-3-3542-2511 · NCCH2414_office@ml.res.ncc.go.jp
Always discuss trial participation with your own doctor first.
| Chiba Cancer Center | Chiba, Chiba, Japan | Recruiting |
| Kyushu Cancer Center | Fukuoka, Fukuoka, Japan | Not Yet Recruiting |
| Gifu University Hospital | Gifu, Gifu, Japan | Not Yet Recruiting |
| Gunma University Hospital | Maebashi, Gunma, Japan | Not Yet Recruiting |
| Hiroshima University Hospital | Hiroshima, Hiroshima, Japan | Not Yet Recruiting |
| St. Marianna University Hospital | Kawasaki, Kanagawa, Japan | Recruiting |
| Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center | Yokohama, Kanagawa, Japan | Not Yet Recruiting |
| Saitama Prefectural Cancer Center | Ina, Kitaadachi-gun, Japan | Not Yet Recruiting |
| Osaka International Cancer Institute | Osaka, Osaka, Japan | Not Yet Recruiting |
| Osaka Medical and Pharmaceutical University Hospital | Takatsuki, Osaka, Japan | Not Yet Recruiting |
| Saitama Medical University International Medical Center | Hidaka, Saitama, Japan | Not Yet Recruiting |
| Shizuoka Cancer Center | Nagaizumi-chō, Sunto-gun, Japan | Not Yet Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07699939